Thursday, November 12, 2026

Tag: drug

Browse our exclusive articles!

US drug tariff risk limited for Indian pharma; Sun Pharma exposure in focus: Vishal Manchanda

Vishal Manchanda, Pharma Analyst, Systematix Group, said potential US tariffs on pharmaceuticals are unlikely to have a broad impact on Indian drug makers, as...

Marksans Pharma shares jump over 8% after USFDA nod for lung infection treatment drug

Shares of Marksans Pharma Ltd. gained over 8% on Wednesday, April 1, after the company said the US Food and Drug Administration (USFDA) has...

Lupin gets USFDA tentative approval for Sugammadex surgical drug

Lupin Ltd. has received tentative approval from the US Food and Drug Administration (USFDA) for its Sugammadex Injection, according to an exchange filing on...

Psychedelic therapies are becoming mainstream. Deutsche Bank thinks this drug developer could triple

Deutsche Bank backs AtaiBeckley in the Psychedelic Renaissance, citing drugs BPL-003, VLS-01 and EMP-01 and projecting multibillion dollar sales after FDA approval.Deutsche Bank believes...

GLP-1 drug and impact on pharma companies – some gainers, some losers

Brokerage firm UBS, in its latest note on the pharma sector, said the generic GLP-1 segment is likely to remain intensely competitive across the...

Popular

Prashant Jain sees 12-15% annual returns from Indian equities over 3-5 years

Question We've had a very painful period for the equity...

Raamdeo Agrawal sees FIIs return as earnings improve and valuations turn attractive

Question Looking at the valuation compression across the market, are...

Stocks to Watch for November 2: Reliance Industries, Jio Platforms, BEL, Vodafone Idea, IOC, M&M and more

From Reliance Industries and Jio Platforms reporting strong quarterly...

Nvidia chief Jensen Huang reportedly targeted in Chinese spy plot | World News

By Jonathan Swan , Maggie Haberman , Ana Swanson...

Subscribe

spot_imgspot_img